Catalyst Biosciences Inc (NASDAQ: CBIO) stock closed at $22.51 on 1/12/24 after a major decline of -14.6%. However, this decline was accompanied by unusually low trading volume at 58% of normal. The stock has been […]
Daqo New Energy Corp (NYSE: DQ). Important negative changes in fundamentals have recently occurred: the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased […]
TechTarget Inc (NASDAQ: TTGT) stock closed at $34.81 on 1/12/24 after a major decline of -12.2%. Moreover, this decline was accompanied by exceptionally high trading volume at 313% of normal. The stock has risen 2.4% […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Companhia de Saneamento Basico d (NYSE: SBS) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price […]
Netease Inc (NASDAQ: NTES) has recently experienced meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2023 decreased significantly, and the consensus estimate for December, 2024 decreased significantly. Recent […]
Extremely significant positive changes in CF Bankshares Inc (NASDAQ: CFBK) investment behavior have recently occurred: positive upside/downside volume developed, and its longer term price trend turned up. Important positive changes in CF Bankshares Inc (NASDAQ: […]
Stock Rating Upgrade The Value Trend Rating for Community West Bancshares (NASDAQ: CWBC) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Recent extremely meaningful negative changes in investment behavior have impacted ModivCare Inc (NASDAQ: MODV): negative upside/downside volume developed, and its shorter term price trend turned down. ModivCare Inc (NASDAQ: MODV) has recently experienced notable negative […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Exelixis Inc (NASDAQ: EXEL) improved recently. EXEL’s current Value Trend Rating is B and the prior Rating was C. Details […]
Stock Rating Downgrade The Value Trend Rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research